Prairie Cancer Consortium leadership and members share updates with the Network

On Thursday, September 26th, leadership and researchers from the Prairie Cancer Consortium (PR2C) presented their work to Network members as part of the MOHCCN seminar series

This series, which is being held periodically throughout the year, features virtual talks from MOHCCN leadership, investigators and trainees from each region, providing a platform for MOHCCN members to share their ongoing work in precision oncology with the wider Network. 

This event was co-chaired by Debbie Duclos, a registered nurse and member of the MOHCCN Patient Working Group from Campbellville, ON, and Véronique LeBlanc, PhD, Program Manager and Scientific Writer, MOHCCN.

Watch the full video

 

Speakers

PR2C CONSORTIUM ACTIVITIES UPDATE

Dr. Jennifer Chan - Associate Professor, Cumming School of Medicine, Department of Pathology and Laboratory Medicine, University of Calgary; Director, Arnie Charbonneau Cancer Institute; MOHCCN consortium lead (PR2C)

RESEARCH PRESENTATIONS

Precision Choice at the Point of Care

Dr. Laura Hopkins - Professor, Department of Oncology, College of Medicine, University of Saskatchewan; Gynecologic oncologist, Saskatchewan Cancer Agency; MOHCCN cohort lead

Predicting response to immune checkpoint blockades in sarcoma

Dr. Hyojin Song - Postdoctoral associate, Morrissy lab, Cumming School of Medicine, University of Calgary